CTAS

Stock splits

$CTAS chatter on StockTwits

• 
  LSTMLabs@RocroBioBullish12h

  $CTAS $TRV $ICE $ADP

  View on StockTwits ↗
• 
  Mr. Denny@EquityResearch66d

  Often times, the best stock to buy is not a new idea. It’s more of what you already own. That’s the lesson from this week’s earnings. $PH and $HONA both reported, but the outcomes were very different. Parker Hannifin continued delivering as a proven industrial compounder. Honeywell Aerospace, on the other hand, disappointed after the spin-off. I was already cautious on HONA before the separation, explaining why it was not a $GE-style situation. But I ignored my own research and got pulled into the new story. The same lesson applies to $ROL vs $CTAS. Different companies, but both show how quality businesses can earn premium valuations over time. Going forward, I’m not planning to add more HONA and may consider selling. New companies are harder to evaluate, especially after earnings volatility and potential tax-loss selling pressure. Sometimes the best move is not chasing the newest opportunity. Sometimes it’s simply adding more to the businesses that have already proven themselves. NFA. DYOR.

  View on StockTwits ↗
• 
  DK@goinbananasBullish6d

  $FIGS damn that looks good…Great earnings, and a lot more to come!  $HBI $LULU $SPY $CTAS

  View on StockTwits ↗
• 
  Dividend Power@DividendPowerBullishAug 1

  Recent Dividend Increases - Updated 08/01/26 https://www.dividendpower.org/dividend-increases/ $HWM $CTAS $KWR $AWR $RSG

  View on StockTwits ↗
• 
  Richard Smith@richardms20BullishJul 30

  $CTAS "Cintas Corporation (NASDAQ: CTAS) currently holds a highly bullish long-term outlook, bolstered by a record-breaking Q4 and full-year fiscal 2026 earnings report alongside strong initial revenue guidance for fiscal 2027. Trading near the top of its 52-week range around $216 to $217, the leading uniform rental and facility services provider recently triggered massive institutional target upgrades from major Wall Street firms like Wells Fargo and Bank of America following a strong "beat-and-raise" quarter. PT $222: Adjusted diluted EPS accelerated 18.3% year-over-year to $1.29 per share, beating Wall Street's consensus projections by $0.05. Cintas is acquire UniFirst (NYSE: UNF), the third-largest industry competitor. While the company received a routine "second request" for information from the FTC, shareholder approval has been finalized, and the merger is expected to close in the second half of calendar 2026 to exponentially boost Cintas's market density."

  View on StockTwits ↗
• 
  TalkMarkets@TalkMarketsJul 29

  Cintas Corporation Dividend Increase $CTAS https://talkmarkets.com/article/cintas-corporation-dividend-increase-1785343482

  View on StockTwits ↗
• 
  Andres@Andresstocks26BullishJul 24

  $ORLY $CTAS $AZO The cyclical part in chips is happening, the Mag 7 aren’t doing so well, investors won’t know where to go because tech will take a hit, nothing looks compelling enough to invest or start a postion. This is when these names will appear in investors radars and notice great companies with cheaper valuations compared to the tech space.

  View on StockTwits ↗
• 
  Hov@OnlyFibsBullishJul 24

  The structural expansion on Cintas Corporation $CTAS is holding firm near $201.36 on the 8-hour chart following a powerful high-volume push through macro resistance. Bullish Leaning Flow : Heavy buy volume is providing clear validation for trend continuation, showing strong institutional backing on the tape as value areas shift higher. Active swing traders are watching this volume node closely for continued upside expansion. 🐂🎯 Bull Key Levels: A confirmed push past $204.00 opens up clear skies toward multi-month highs. 🐂🔥 Bear Key Levels: Defensive bulls must protect the $190.00 volume shelf at all costs to prevent a structural reversal. 🐻⚠️ Take Profit Targets: $215.00 / $228.00. 💰💸 #hovdid #CTAS #SwingTrading #PriceAction #GrowthStock #StockTrading

  View on StockTwits ↗
• 
  stage2.trading@stagetwotradingBullishJul 22

  $CTAS - Grade A+ Stop loss @ 188.4

  View on StockTwits ↗
• 
  Hov@OnlyFibsBullishJul 19

  $CTAS is consolidating after the recent post-earnings volatility. The stock is currently trading around $204.45, looking to stabilize following the Q4 earnings beat. Watching for volume to confirm if this range holds or if we see a continuation of the recent trend. 🐂🎯 Bull Key Levels: A clean breakout and sustained close above $210 is required to signal further upside toward the 52-week highs. 🐂🔥 Bear Key Levels: Holding the $201.50 support zone is critical to prevent a slide back into the $190S. 🐻⚠️ Take Profit Targets: $215 / $220. 💰💸 #hovdid #ctas #stocks #trading #optionsflow

  View on StockTwits ↗
• 
  Craig HOUPT@HouptyJul 18

  $CTAS a bit of a dip today.

  View on StockTwits ↗
• 
  par cha@parchaJul 16

  $ctas Cintas — The uniform rental and laundering service stock jumped 6.5% after a Bank of America upgrade to buy from neutral. The rating change comes after Cintas on Wednesday posted better-than-expected earnings for the fiscal fourth quarter. “We are incrementally more constructive on the setup for earnings over the next several quarters as Cintas benefits from an improved backdrop in key labor verticals, continues to drive impressive growth in adjacent product categories and is generating outsized margin gains from a high focus on improving supply chain and distribution efficiencies,” BofA said https://www.cnbc.com/2026/07/15/stock-market-today-live-updates.html?__source=iosappshare%7Ccom.stocktwits.StockTwits.STShareExtension

  View on StockTwits ↗
• 
  Top Stock Alerts@topstockalertsJul 16

  $CTAS there’s a lot less friction here than I expected.

  View on StockTwits ↗
• 
  Zack Trades@Alphatrades09Jul 16

  $CTAS 215C 8/21 — 1.10

  View on StockTwits ↗
• 
  Rob Lewis@IN0V8Jul 16

  $CTAS Jefferies raises target price to $210 from $200 Wells Fargo raises target price to $250 from $245

  View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.